ResMed: Result 2014
It's been a tough year for ResMed, but the manufacturer of respiratory aids still delivered a 9% rise in earnings per share.
Supermarket superwars - Part 1
The world’s most competitive supermarket sector is facing turmoil and there may be some lessons for investors in Woolies and Wesfarmers.
Electricity disrupted - Part 2
The venerable electricity business has become vulnerable. We examine the impact on AGL, Origin, Spark, SP Ausnet and their smaller competitors.
QBE downgraded to Sell
QBE has warned of another poor result, this time due to workers' compensation losses in Latin America. After five long years we've lost our patience.
Telstra climbs the food chain
The dominant telco is trying to escape competition in its physical network by getting closer to its customers, but it will find competition there as well.
Five reasons to buy Transpacific
Transpacific has cleaned up its act under new management yet its share price is still down in the dumps.
Pact eyes Asian expansion
The market has been unimpressed with Pact since it floated late last year, but there's growth potential in Asia's expanding middle class.
Silex: Fission for opportunity
A small Australian technology business could turn the nuclear industry on its head and, in doing so, could make investors rich.
Acrux: The bear case
Acrux is the second most shorted stock on the ASX but, as Graham Witcomb explains, the bear case doesn't stack up.
Call 1300 880 160
Start a chat
Schedule a call
